Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Selenium inhibition of survivin expression by preventing Sp1 binding to its promoter.

Selenium inhibition of survivin expression by preventing Sp1 binding to its promoter. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Selenium inhibition of survivin expression by preventing Sp1 binding to its promoter. Abstract Text:

    jae yeon chunJae Yeon Chun,yan huYan Hu,elaine pinderElaine Pinder,jianguo wuJianguo Wu,fengzhi liFengzhi Li,allen c gaoAllen C Gao,

    Survivin, an antiapoptotic protein highly expressed in cancer, regulates multiple cellular network associated with cancer cell viability and drug resistance. Inhibition of survivin expression has been pursued as a valid cancer therapeutic target. In this study, we showed that selenium, an effective chemopreventive agent for many types of cancers, down-regulated survivin expression. Selenium inhibited survivin expression in both mRNA and protein levels in a dose- and time-dependent manner. Using a series of survivin promoter-luciferase constructs, a 37-bp DNA element in the survivin core promoter region that mediates the ability of selenium to inhibit survivin transcription was identified. Gel mobility shift assays and chromatin immunoprecipitation analyses revealed that selenium prevents the binding of Sp1 or Sp1-like proteins to the 37-bp cis-acting DNA element in the survivin promoter. Furthermore, inhibition of survivin expression by small interfering RNA enhanced selenium's inhibitory effects on cell growth, whereas overexpression of survivin in LNCaP human prostate cancer cells desensitized cancer cells to selenium effect, suggesting that the expression of survivin plays an important role in determining the response of cancer cells to selenium. Taken together, these results suggest that selenium down-regulated survivin expression by preventing the binding of Sp1 or Sp1-like proteins to the promoter of survivin, which contributes at least in part to the inhibitory effect of selenium on survivin gene transcription. In addition, down-regulation of survivin expression may account for one of the molecular mechanisms of the anticancer effects of selenium.

    Selenium inhibition of survivin expression by preventing Sp1 binding to its promoter. Publishing Authors By Initials

    jy chunJY Chun,y huY Hu,e pinderE Pinder,j wuJ Wu,f liF Li,ac gaoAC Gao,

    For similar investigative techniques: genetic techniques: gene transfer techniques: transfection research abstracts see: investigative techniques: genetic techniques: gene transfer techniques: transfection research

    PUBMED ID PMID:

    MEDLINE DATE:

    Selenium inhibition of survivin expression by preventing Sp1 binding to its promoter. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Molecular cancer therapeutics

    VOLUME: 6

    Page Numbers: 2572-80

    Journal Abbreviation: Mol. Cancer Ther.

    ISSN: 1535-7163

    DAY: 27

    MONTH: Sep

    YEAR: 2007

    Selenium inhibition of survivin expression by preventing Sp1 binding to its promoter. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 101132535

    Selenium inhibition of survivin expression by preventing Sp1 binding to its promoter. Keywords Mesh Terms:

    KEYWORDS: Transfection

    MESH TERMS: drug effects

    Chemical & Substance for Abstract: Selenium inhibition of survivin expression by preventing Sp1 binding to its promoter. Information

    Substance Name: Luciferases

    Registry Number: EC 1.13.12.-

    Grant and Affiliation Information for Selenium inhibition of survivin expression by preventing Sp1 binding to its promoter.

    AFFILIATION: Department of Medicine, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NCI

    GRANT: CA109481

    ACRONYM: CA

    MEDLINETA: Mol Cancer Ther

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Selenium inhibition of survivin expression by preventing Sp1 binding to its promoter Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News